mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0011 |
1 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.00097 |
1 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
0.00099 |
1 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.00095 |
1 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00061 |
1 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.00054 |
1 |